Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Liver tumor vasculature refers to the network of blood vessels that supply nutrients and oxygen to liver tumors. This network is crucial for tumor growth, progression, invasion, and metastasis. It is characterized by aberrant angiogenesis, driven primarily by the VEGF/VEGFR and Angiopoietin/Tie pathways. Targeting this vasculature is a major therapeutic approach in liver cancer.
Anti-angiogenic therapies inhibit the formation of new blood vessels, thereby starving the tumor of nutrients and oxygen. Nanoparticle-based delivery enhances drug accumulation at the tumor site while minimizing systemic toxicity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Liver Tumor Vasculature (N/A).